Bio-Rad Laboratories (BIO) Long-Term Investments (2012 - 2026)

Bio-Rad Laboratories (BIO) has 15 years of Long-Term Investments data on file, last reported at $5.3 billion in Q1 2026.

• On a quarterly basis, Long-Term Investments rose 6.36% year-over-year to $5.3 billion in Q1 2026; TTM through Mar 2026 was $5.3 billion, a 6.36% increase from a year earlier, with the FY2025 full-year figure at $6.1 billion, up 26.13% from the prior year.
• Long-Term Investments for Q1 2026 stood at $5.3 billion, down from $6.1 billion in the prior quarter.
• Over the last five years, Long-Term Investments for BIO reached as high as $9.7 billion in Q1 2022 and fell as low as $4.8 billion in Q4 2024.
• Historically, Long-Term Investments has averaged $6.8 billion across 5 years, with a median of $7.2 billion in 2023.
• Across the five-year window, Long-Term Investments slumped 54.04% in 2022 and rose 26.13% in 2025, its largest moves.
• Year by year, Long-Term Investments stood at $8.8 billion in 2022, then decreased by 12.83% to $7.7 billion in 2023, then plunged by 37.14% to $4.8 billion in 2024, then increased by 26.13% to $6.1 billion in 2025, then retreated by 12.97% to $5.3 billion in 2026.
• Per Business Quant data, the three most recent Long-Term Investments figures were $5.3 billion in Q1 2026, $6.1 billion in Q4 2025, and $5.1 billion in Q3 2025.